Movement Disorders (revue) - Checkpoint (Istex)

Index « Keywords » - entrée « ropinirole »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
root mean square < ropinirole < ropinirole prolonged release  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000192 (2011) Mauro Manconi [Italie, Suisse] ; Raffaele Ferri [Italie] ; Marco Zucconi [Italie] ; Alessandro Oldani [Italie] ; Laura Giarolli [Italie] ; Valentina Bottasini [Italie] ; Luigi Ferini-Strambi [Italie]Pramipexole versus ropinirole: Polysomnographic acute effects in restless legs syndrome
000230 (2011) Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni]PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease
000B40 (2010) Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
001652 (2007) Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
001657 (2007) Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni]Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease
001702 (2007) Yoshikuni Mizuno [Japon] ; Takashi Abe [Japon] ; Kazuko Hasegawa [Japon] ; Sadako Kuno [Japon] ; Tomoyoshi Kondo [Japon] ; Mitsutoshi Yamamoto [Japon] ; Mitsuyoshi Nakashima [Japon] ; Ichiro Kanazawa [Japon]Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study
001B70 (2007) Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni]A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease
001C56 (2006) Jacques Montplaisir [Canada] ; Jeff Karrasch [Australie] ; Jean Haan [Allemagne] ; Dieter Volc [Autriche]Ropinirole is effective in the long‐term management of restless legs syndrome: A randomized controlled trial
001F52 (2006) Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
002356 (2005) Charlotte Meindorfner [Allemagne] ; Yvonne Körner [Allemagne] ; Jens Carsten Möller [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Wolfgang Hermann Oertel [Allemagne] ; Hans-Peter Krüger [Allemagne]Driving in Parkinson's disease: Mobility, accidents, and sudden onset of sleep at the wheel
002521 (2004) Arthur S. Walters [États-Unis] ; William G. Ondo [États-Unis] ; Tilman Dreykluft [Allemagne] ; Ron Grunstein [Australie] ; Daniel Lee [États-Unis] ; Kapil Sethi [États-Unis]Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12‐week, double‐blind, randomized, parallel‐group, placebo‐controlled study
002954 (2003) Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique]Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset
002C97 (2002) Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France]Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats
003100 (2001) Eleni C. Maratos [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Antiparkinsonian activity and dyskinesia risk of ropinirole and L‐DOPA combination therapy in drug naive MPTP‐lesioned common marmosets (Callithrix jacchus)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i -k "ropinirole" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i  \
                -Sk "ropinirole" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    ropinirole
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024